- Telangana leads localization in MedTech and AI-driven life sciences
- Experts highlight India’s 70% import gap and new AI frontiers in health sciences
The next big boom after the IT revolution will be in Medical Devices, said Venugopala Rao Sankineni, Vice President – Medical Devices Policy & Investments, Telangana Lifesciences, Government of Telangana. He made this statement while addressing Day 2 of the TG-PackCON 2025 Vision Edition, a two-day Summit for Economic Growth hosted by the Confederation of Indian Industry (CII) at The Park, Somajiguda, Hyderabad.
He called Hyderabad the powerhouse of India’s pharma sector and outlined Telangana’s four-pronged growth strategy: attracting investments, fostering innovation, upskilling talent, and building world-class infrastructure in pharma and life sciences. Emphasising the importance of MSMEs, he said that future progress in life sciences lies where biology meets technology. He detailed the Digital Health Data Exchange initiative, a unified state-led health data portal for advanced digital integration. With India’s MedTech industry valued at USD 14 billion and growing at 14% annually, he underscored that 70% of medical devices are still imported and stressed the need for faster indigenisation.
He also mentioned the Medical Devices Park at Sultanpur, Patancheru — India’s largest MedTech R&D and manufacturing cluster — which is now expanding in its second phase. With this infrastructure, Hyderabad is rapidly emerging as a global destination for medical tourism.
Dr. Reddanna Pallu, Executive President, Federation of Asian Biotech Association (FABA), noted that India’s share in the global biopharma market stands at only 0.3%. He urged for accelerated innovation through the FABA Academy initiative, which connects startups, investors, and scientific leaders to create a stronger biotech ecosystem with better skill development.
British Deputy High Commissioner Gareth Wynn Owen highlighted that the India-UK Free Trade Agreement is the broadest trade deal between the two countries. With a projected 50% jump in bilateral trade from the current £43 billion, he said that it opens new doors for collaboration in medical devices and MedTech innovation.
Earlier, TG-PackCON 2025 Chairman Chakravarthi AVPS, also MD of Ecobliss India, opened Day 2 with a strong message: “A future economy cannot be built on linear thinking. Innovation is no longer a choice, it is a responsibility.” The day featured sessions by Dr. Vinay Kumar Gupta of CDSCO, who spoke on Telangana’s growing global footprint in active pharmaceutical ingredients, and Girish Kapur from United States Pharmacopoeia (USP), who said, “Excellence does not happen by accident, it is a journey we are all part of.”
The event also featured a “Disruptor Talk” by Jignesh Talasila, Co-Founder & CEO of Perspective AI, who discussed AI’s deep role in drug discovery. He showcased Google DeepMind’s C2S-Scale system, which reduced cancer drug discovery timelines from years to weeks. He also spoke about AI-powered Character Twins, which simulate digital patients to test diagnostics before human trials. Predicting the next phase of AI in healthcare, he remarked, “AI will stop reacting and start foreseeing,” hinting at a paradigm where computers simulate disease progression and treatments ahead of symptoms.
TG-PackCON 2025 closed with optimism about Telangana’s leadership role in medical devices, biotech, and AI-powered health innovation — setting the stage for India’s next big leap beyond IT.
Now you can get the latest stories from Indtoday on Telegram every day. Click the link to subscribe. Click to follow Indtoday’s Facebook page, Twitter, and Instagram. For all the latest Hyderabad News updates
